Arcadia Biosciences (RKDA) Gains from Investment Securities (2018 - 2025)

Arcadia Biosciences (RKDA) has 6 years of Gains from Investment Securities data on file, last reported at -$1.0 million in Q2 2025.

• Quarterly Gains from Investment Securities changed N/A year-over-year to -$1.0 million in Q2 2025, while the trailing twelve-month figure through Dec 2025 was -$2.0 million (changed N/A YoY) and the FY2025 annual result came in at -$2.0 million, changed N/A from the prior year.
• Gains from Investment Securities held at -$1.0 million in Q2 2025, from -$1.0 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $498000.0 in Q2 2021 to a low of -$1.0 million in Q1 2025.
• A 3-year average of -$254571.4 and a median of -$70000.0 in 2021 frame the typical range for Gains from Investment Securities.
• Annual changes were most pronounced in 2021 — Gains from Investment Securities jumped 98.28% — and 2022, when it slumped 107.83%.
• Tracing RKDA's Gains from Investment Securities over 3 years: stood at -$70000.0 in 2021, then surged by 44.29% to -$39000.0 in 2022, then sank by 2464.1% to -$1.0 million in 2025.
• The last three Gains from Investment Securities figures came in at -$1.0 million (Q2 2025), -$1.0 million (Q1 2025), and -$39000.0 (Q2 2022), per Business Quant data.